Please ensure Javascript is enabled for purposes of website accessibility

Curaleaf Says Select Acquisition to Close Within Weeks

By Eric Volkman - Jan 17, 2020 at 2:15PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The cannabis company provides an update on the Select deal, plus two other pending acquisitions.

Curaleaf (CURLF -1.39%) will finally take possession of the Select brand of cannabis products soon -- if an estimation by the company proves correct. On Friday, Curaleaf issued an update about this pending acquisition, plus two others.

The company said it and Select have met all requirements for the acquisition, save for the transfer of a license in Oregon. The two are working with state officials to secure approval, Curaleaf said, and the deal should finally close by Feb. 1.

This has been dragging for quite some time. Curaleaf first announced it bought Cura Partners -- the company behind Select -- last May. The price was the equivalent of around $950 million, to be paid entirely in stock. The terms and scope of the Curaleaf/Select deal, however, were subsequently amended to value the transaction at roughly $286 million

Marijuana leaves and bottles of derivative product.

Image source: Getty Images

The company also shared a scrap of news about another pending transaction, its deal to buy dispensary operator Grassroots. Curaleaf and its asset-to-be "have each submitted certifications of substantial compliance" to regulators in order to push the deal through. Originally announced in July, Curaleaf's update said the acquisition should close this spring. The deal was valued at around $875 million when it was made public.

Finally, Curaleaf said it filed an application for change of control with Massachusetts's cannabis regulator in its pending takeover of dispensary operator Alternative Therapies Group (ATG), which like Curaleaf is headquartered in that state. As with Select, Curaleaf asserts that it and ATG are laboring to win approval for the $50 million all-cash deal as soon as they can.

Curaleaf, a popular marijuana stock, is up by almost 2% in mid-afternoon trading Friday.


Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$5.76 (-1.39%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.